$16.90
4.63% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US44842L1035
Symbol
HCM
Sector
Industry

Hutchison China MediTech Limited Sponsored ADR Stock price

$16.90
+3.76 28.61% 1M
+1.32 8.47% 6M
+2.49 17.28% YTD
-1.74 9.33% 1Y
-5.45 24.38% 5Y
+3.50 26.12% 10Y
+3.50 26.12% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.82 4.63%
ISIN
US44842L1035
Symbol
HCM
Sector
Industry

Key metrics

Market capitalization $3.13b
P/E (TTM) P/E ratio 422.50
P/S ratio (TTM) P/S ratio 4.96
Revenue growth (TTM) Revenue growth -24.80%
Revenue (TTM) Revenue $630.20m
EBIT (operating result TTM) EBIT $-43.71m
Free Cash Flow (TTM) Free Cash Flow $-17.44m
EPS (TTM) EPS $0.04
P/E forward 8.57
P/S forward 4.53
Short interest 0.47%
Show more

Is Hutchison China MediTech Limited Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Hutchison China MediTech Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Hutchison China MediTech Limited Sponsored ADR forecast:

22x Buy
88%
3x Hold
12%

Analyst Opinions

25 Analysts have issued a Hutchison China MediTech Limited Sponsored ADR forecast:

Buy
88%
Hold
12%

Financial data from Hutchison China MediTech Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
630 630
25% 25%
100%
- Direct Costs 349 349
9% 9%
55%
281 281
38% 38%
45%
- Selling and Administrative Expenses 113 113
15% 15%
18%
- Research and Development Expense 212 212
30% 30%
34%
-31 -31
218% 218%
-5%
- Depreciation and Amortization 12 12
50% 50%
2%
EBIT (Operating Income) EBIT -44 -44
338% 338%
-7%
Net Profit 38 38
63% 63%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Hutchison China MediTech Limited Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hutchison China MediTech Limited Sponsored ADR Stock News

Neutral
GlobeNewsWire
10 days ago
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) and Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801) today jointly announce that the New Drug Application (“NDA”) for the combination of fruquintinib and sintilimab for the treatment of patients with locally advanced or metastatic renal cell carci...
Neutral
GlobeNewsWire
13 days ago
— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study —
Neutral
GlobeNewsWire
23 days ago
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, fruquintinib and surufatinib, will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting taking plac...
More Hutchison China MediTech Limited Sponsored ADR News

Company Profile

Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.

Head office Cayman Islands
CEO Wei Su
Founded 2000
Website www.hutch-med.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today